CA2085291A1 - Tyrosine kinase receptrice - Google Patents

Tyrosine kinase receptrice

Info

Publication number
CA2085291A1
CA2085291A1 CA 2085291 CA2085291A CA2085291A1 CA 2085291 A1 CA2085291 A1 CA 2085291A1 CA 2085291 CA2085291 CA 2085291 CA 2085291 A CA2085291 A CA 2085291A CA 2085291 A1 CA2085291 A1 CA 2085291A1
Authority
CA
Canada
Prior art keywords
protein
tyrosine kinase
tek
receptor tyrosine
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2085291
Other languages
English (en)
Inventor
Martin L. Breitman
Janet Rossant
Daniel J. Dumont
Terry P. Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mount Sinai Hospital Corp
Original Assignee
Mount Sinai Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital Corp filed Critical Mount Sinai Hospital Corp
Publication of CA2085291A1 publication Critical patent/CA2085291A1/fr
Abandoned legal-status Critical Current

Links

CA 2085291 1992-07-30 1992-12-14 Tyrosine kinase receptrice Abandoned CA2085291A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92179592A 1992-07-30 1992-07-30
US07/921,795 1992-07-30

Publications (1)

Publication Number Publication Date
CA2085291A1 true CA2085291A1 (fr) 1994-01-31

Family

ID=25445988

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2085291 Abandoned CA2085291A1 (fr) 1992-07-30 1992-12-14 Tyrosine kinase receptrice

Country Status (1)

Country Link
CA (1) CA2085291A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021866A1 (fr) * 1994-02-10 1995-08-17 Ludwig Institute For Cancer Research Molecule immuno-interactive se liant au domaine extracellulaire du recepteur tie2/tek
US5840301A (en) * 1994-02-10 1998-11-24 Imclone Systems Incorporated Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
US5861499A (en) * 1994-02-10 1999-01-19 Imclone Systems Incorporated Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
US5955311A (en) * 1994-02-10 1999-09-21 Imclone Systems Incorporated Monoclonal antibodies specific to VEGF receptors and uses thereof
EP1046715A1 (fr) * 1999-04-23 2000-10-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction de la protéine vasculaire endothelial tyrosine phosphatase et le récepteur Tie-2 d'angiopoietine
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
US6811779B2 (en) 1994-02-10 2004-11-02 Imclone Systems Incorporated Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
US6936586B1 (en) 1996-01-18 2005-08-30 Steeno Research Group A/S Synthetic IL-10 analogues
US7972596B2 (en) 2004-11-18 2011-07-05 Imclone Llc Antibodies against vascular endothelial growth factor receptor-1

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448077B1 (en) 1994-02-10 2002-09-10 Imclone Systems, Inc. Chimeric and humanized monoclonal antibodies specific to VEGF receptors
US6365157B2 (en) 1994-02-10 2002-04-02 Imclone Systems, Inc. Monoclonal antibodies specific to VEGF receptors and uses thereof
US5861499A (en) * 1994-02-10 1999-01-19 Imclone Systems Incorporated Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
US5955311A (en) * 1994-02-10 1999-09-21 Imclone Systems Incorporated Monoclonal antibodies specific to VEGF receptors and uses thereof
US6811779B2 (en) 1994-02-10 2004-11-02 Imclone Systems Incorporated Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
WO1995021866A1 (fr) * 1994-02-10 1995-08-17 Ludwig Institute For Cancer Research Molecule immuno-interactive se liant au domaine extracellulaire du recepteur tie2/tek
US5840301A (en) * 1994-02-10 1998-11-24 Imclone Systems Incorporated Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
US6599501B1 (en) 1994-07-05 2003-07-29 Steeno Research Group A/S Immunomodulators
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
US6168791B1 (en) 1994-07-05 2001-01-02 Steeno Research Group A/S Antibodies that bind immunomodulators
US6936586B1 (en) 1996-01-18 2005-08-30 Steeno Research Group A/S Synthetic IL-10 analogues
WO2000065085A1 (fr) * 1999-04-23 2000-11-02 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction de proteine-tyrosine phosphatase vasculaire-endotheliale avec le recepteur angiopoietine tie-2
EP1046715A1 (fr) * 1999-04-23 2000-10-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction de la protéine vasculaire endothelial tyrosine phosphatase et le récepteur Tie-2 d'angiopoietine
US7972596B2 (en) 2004-11-18 2011-07-05 Imclone Llc Antibodies against vascular endothelial growth factor receptor-1
US8143025B2 (en) 2004-11-18 2012-03-27 Imclone Llc Antibodies against vascular endothelial growth factor receptor-1

Similar Documents

Publication Publication Date Title
Holash et al. Reciprocal expression of the Eph receptor Cek5 and its ligand (s) in the early retina
AU763483B2 (en) Artery- and vein-specific proteins and uses therefor
Wright et al. Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction
Haigh et al. The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network
EP1319408A1 (fr) M dicaments contre les d faillances cardiaques
US20110195901A1 (en) Artery- and vein-specific proteins and uses therefor
JP2000517185A (ja) 新規なメタロプロテアーゼファミリーｋｕｚ
Cheng et al. The murine LIM-kinase gene (limk) encodes a novel serine threonine kinase expressed predominantly in trophoblast giant cells and the developing nervous system
JPH11507527A (ja) 発生的に調節される内皮細胞遺伝子座−１
WO1996040769A9 (fr) Locus-1 de cellules endotheliales a developpement regule
US5681714A (en) Nucleic acid encoding tek receptor tyrosine kinase
Marsden et al. Cloning and characterization of novel β integrin subunits from a sea urchin
CA2085291A1 (fr) Tyrosine kinase receptrice
US5466596A (en) Tissue specific transcriptional regulatory element
JP2003501026A (ja) 脂質代謝転写因子
JP2006525784A (ja) 膜貫通型タンパク質ａｍｉｇｏおよびその用途
Ohneda et al. Combined action of c-kit and erythropoietin on erythroid progenitor cells
JP2004502444A (ja) 筋選択的カルシニューリン相互作用タンパク質（ｍｃｉｐ）に関連する方法および組成物
US6607914B1 (en) Camello gene family and uses thereof
US6911533B1 (en) Pancreatic progenitor 1 gene and its uses
US20020142415A1 (en) Novel polypeptides and polynucleotides and methods of using them
JP2001502906A (ja) Ｄｓ―ｃａｍタンパク質をコードする核酸およびそれに関連する産物
JP2003523762A (ja) ＧＦＲα４に関連するかまたはそれから誘導される化合物、およびその使用
JP3347314B2 (ja) マウス接着分子オクルディン
Stein The Eph receptor, ELK, plays an essential role in signaling endothelial cell aggregatory responses utilizing specific signaling molecules

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead